|
THIS ENDORSEMENT CHANGES THE POLICY. PLEASE READ IT CAREFULLY.
<br />Form SL 21 17 09 24 Page 1 of 1
<br />© 2024, The Hartford
<br />(May include copyrighted material of Insurance Services Office, Inc., with its permission)
<br />EXCLUSION – ENDOCRINE DISRUPTORS
<br />This endorsement modifies insurance provided under the following:
<br />BUSINESS LIABILITY COVERAGE FORM
<br />Except as otherwise stated in this endorsement, the terms and conditions of the Policy apply.
<br />A.The following exclusion is added to Section B. EXCLUSIONS:
<br />This insurance does not apply to:
<br />1.Any damages,judgments,settlements,loss,costs or expenses,or any other form of relief,remedy or recovery
<br />that may be awarded or incurred by reason of any claim or "suit"alleging actual or threatened injury or damage of
<br />any nature or kind,including,but not limited to,"bodily injury","property damage"or "personal and advertising
<br />injury",which arises out of,or relates in any way to exposure to or the presence of “endocrine disruptor(s)”in any
<br />form including but not limited to:
<br />a.manufacturing handling,sale,distribution,marketing,installation,repair,removal,abatement,replacement,or
<br />handling of “endocrine disruptor(s)” or products containing “endocrine disruptor(s)”; or
<br />b.an actual,alleged or threatened discharge,dispersal,seepage,migration,release or escape of "endocrine
<br />disruptor(s)" whether intentional or unintentional; or
<br />c.consumption,ingestion,presence,inhalation or use of,contact with or exposure to,"endocrine disruptor(s)”,
<br />whether by direct or passive exposure.
<br />2.Any loss, cost or expense arising out of any:
<br />a.Request,demand,order,or other requirement (whether statutory or regulatory)that any insured or others test
<br />for,investigate for,monitor,clean up,abate,remove,remediate,contain,treat,detoxify or neutralize,dispose
<br />of, or in any way respond to, or assess the effects of "endocrine disruptor(s)"; or
<br />b.Claim or suit by or on behalf of a governmental authority for damages because of testing for,investigating for,
<br />monitoring,cleaning up,abating,removing,remediating,containing,treating,detoxifying or neutralizing,
<br />disposing of or in any way responding to or assessing the effects of "endocrine disruptor(s)".
<br />B.The following definition is added to Section F. LIABILITY AND MEDICAL EXPENSES DEFINITIONS:
<br />"Endocrine Disruptor(s)"means:
<br />1.Any substance, material, or compound that may mimic, block, or interfere with the body’s hormones,including,
<br />but not limited to:atrazine;bisphenol A (BPA);dioxins;perchlorate;per and polyfluoroalkyl substances (PFAS);
<br />phthalates;phytoestrogens;polybrominated diphenyl ethers (PBDE);polychlorinated biphenyls (PCBs);and
<br />triclosan; or
<br />2.Any substance,material,or compound that is identified or acknowledged by any federal,state,international or
<br />other governmental agency or authority,including but not limited to the United States Environmental Protection
<br />Agency (EPA),the Centers for Disease Control and Prevention (CDC),the Agency for Toxic Substances and
<br />Disease Registry (ATSDR),the National Institutes for Health (NIH),and the International Agency for Research on
<br />Cancer (IARC):
<br />a.To be an endocrine disruptor; or
<br />b.To exhibit or demonstrate the same or similar harmful properties as endocrine disruptors.
<br />3.Any constituents,additives,degradation,break down (metabolites),or by-products to or of any substance,
<br />material or compound set forth in subparagraphs a.and b.above,including but not limited to homologues,
<br />isomers, salts, esters, alcohols, acids, and precursor chemicals, compounds and derivatives.
<br />Docusign Envelope ID: 9DF92A24-B534-85BA-8088-342315DF1839
|